In the media

Investor webinar 5 September 2017

1, September, 2017

Posted In: Featured, In the media, Videos, Blog

Admedus Limited (ASX: AHZ) held an investor webinar on 5 September, 2017 to discuss the results of the Company’s Preliminary Final Report (Appendix 4E) for the year ended 30 June 2017.  Admedus CEO Wayne Paterson will provide a review of the Company’s year-end performance as well as operational and business highlights.

> Read more

Admedus announces exclusive supply agreement with 4C Medical

Admedus announces exclusive supply agreement with 4C Medical

31, August, 2017

Posted In: In the media, Blog

Admedus Limited is pleased to announce that it has entered an exclusive supply agreement with 4C Medical Technologies, Inc. (4C Medical), a Minnesota-based developer of minimally invasive therapies for structural heart disease. Read more here.

> Read more

Admedus beats revenue forecasts for financial year 2017

31, August, 2017

Posted In: Featured, In the media

Admedus has delivered a full year sales increase of 58% to $22.3 million for financial year 2017, compared to the previous financial year. Read more here.

> Read more

Sponsorship supports kids with heart disease

15, August, 2017

Posted In: Featured, In the media

Admedus Ltd is proud to announce a six-month $20k sponsorship of the HeartKids Education Program which provides vital resources for families of children living with congenital/childhood heart disease. In Australia, congenital/childhood heart disease is the leading cause of death for children under a year old and nearly three thousand babies are born with a heart […]

> Read more

Admedus Ltd readies commercial CardioCel® 3D launch

11, July, 2017

Posted In: Featured, In the media

Proactive Investors takes a look at our plans for CardioCel 3D. Read their latest article here.

> Read more

Admedus CEO Wayne Paterson interview with Proactive Investors

4, July, 2017

Posted In: In the media, Videos

Our CEO Wayne Paterson recently shared his thoughts and vision for Admedus in this interview with Proactive Investors. Watch it now.

> Read more

How to regenerate a regenerative company: CEO talks to MassDevice

4, July, 2017

Posted In: Featured, In the media

Our CEO Wayne Paterson was recently interviewed by MassDevice about the progress Admedus is making. Read the story here.  

> Read more

Long-term study indicates no calcification with CardioCel after eight years

22, August, 2016

Posted In: In the media, Uncategorized

Long-term data from a Phase II extension study for the repair of congenital heart defects in paediatrics using CardioCel shows that all patients continue to progress well, with no sign of calcification or need for repeat procedures.

> Read more

Admedus shares rise on hospital infusion pump supply deal with Arcomed

25, May, 2016

Posted In: In the media, Uncategorized

Admedus said today it won a supply contract with the new Royal Adelaide Hospital for the installation of the Arcomed chroma infusion pump systems. The supply tender includes ongoing technical and clinical support as well as consumable products for the systems over the next 5 years.

> Read more

Admedus Wins 2016 Australian Manufacturer of the Year Award

14, May, 2016

Posted In: In the media, Uncategorized

After triumphing in the Most Innovative category, Admedus also took out the night’s biggest award ‘Manufacturer of the Year’. In August 2014 Admedus opened its state-of-the-art bio-manufacturing facility in Malaga, WA, and has experienced huge success in exporting its bio-scaffold regenerative medicine product, CardioCel, since then.

> Read more